Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Raffeld

Showing results (191-200 of 276) with videos related to

Pageof 28
Sort By:
Journal of the National Cancer Institute|April 5, 2017
Evidence for a Mesothelial Origin of Body Cavity Effusion LymphomasDavid Sanchez-Martin, Thomas S Uldrick, Hyeongil Kwak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignanciesDeirdre O'Mahony, John C Morris, Maryalice Stetler-Stevenson, et al.
Haematologica|December 21, 2014
Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorderPaneez Khoury, Jacqueline Herold, Alexandra Alpaugh, et al.
Journal of Global Oncology|July 19, 2017
<i>EGFR</i> Mutations in Latinos From the United States and Latin AmericaAriel Lopez-Chavez, Anish Thomas, Moses O Evbuomwan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenibRonan J Kelly, Arun Rajan, Jeremy Force, et al.
Haematologica|April 22, 2011
Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implicationsKatherine R Calvo, Donald C Vinh, Irina Maric, et al.
The Journal of Clinical Investigation|June 10, 2014
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistanceKang-Seo Park, Mark Raffeld, Yong Wha Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumorsShivaani Kummar, Mark Raffeld, Lamin Juwara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2020
Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase ExpressionDaniel Rathkey, Manakamana Khanal, Junko Murai, et al.
British Journal of Haematology|October 20, 2022
A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusionsTing Zhou, Constance M Yuan, Kathryn Lurain, et al.
Pageof 28

Showing results (191-200 of 276) with videos related to

Sort By:
Pageof 28
Journal of the National Cancer Institute|April 5, 2017
Evidence for a Mesothelial Origin of Body Cavity Effusion LymphomasDavid Sanchez-Martin, Thomas S Uldrick, Hyeongil Kwak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignanciesDeirdre O'Mahony, John C Morris, Maryalice Stetler-Stevenson, et al.
Haematologica|December 21, 2014
Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorderPaneez Khoury, Jacqueline Herold, Alexandra Alpaugh, et al.
Journal of Global Oncology|July 19, 2017
<i>EGFR</i> Mutations in Latinos From the United States and Latin AmericaAriel Lopez-Chavez, Anish Thomas, Moses O Evbuomwan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenibRonan J Kelly, Arun Rajan, Jeremy Force, et al.
Haematologica|April 22, 2011
Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implicationsKatherine R Calvo, Donald C Vinh, Irina Maric, et al.
The Journal of Clinical Investigation|June 10, 2014
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistanceKang-Seo Park, Mark Raffeld, Yong Wha Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumorsShivaani Kummar, Mark Raffeld, Lamin Juwara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2020
Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase ExpressionDaniel Rathkey, Manakamana Khanal, Junko Murai, et al.
British Journal of Haematology|October 20, 2022
A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusionsTing Zhou, Constance M Yuan, Kathryn Lurain, et al.
Pageof 28